Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients

Aditi Shirsat,1 Siddhi Pashilkar,2 Ashish Chavan,1 Devanshi Kalra,2 Vikram Gota,1,3 Amit Joshi,2,3 Manjunath Nookala Krishnamurthy1,3 1Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India; 2Departme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shirsat A, Pashilkar S, Chavan A, Kalra D, Gota V, Joshi A, Nookala Krishnamurthy M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/6950c31bdf904c32aff377dd522dc393
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6950c31bdf904c32aff377dd522dc393
record_format dspace
spelling oai:doaj.org-article:6950c31bdf904c32aff377dd522dc3932021-11-18T19:40:25ZEffect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients1178-6981https://doaj.org/article/6950c31bdf904c32aff377dd522dc3932021-11-01T00:00:00Zhttps://www.dovepress.com/effect-of-the-pandemic-on-quality-of-life-data-collection-in-prostate--peer-reviewed-fulltext-article-CEORhttps://doaj.org/toc/1178-6981Aditi Shirsat,1 Siddhi Pashilkar,2 Ashish Chavan,1 Devanshi Kalra,2 Vikram Gota,1,3 Amit Joshi,2,3 Manjunath Nookala Krishnamurthy1,3 1Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India; 2Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India; 3Homi Bhabha National Institute, Mumbai, Maharashtra, IndiaCorrespondence: Manjunath Nookala KrishnamurthyDepartment of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector- 22, Kharghar, Navi Mumbai, 410210, Maharashtra, IndiaTel +91 2268735130Email mnookala@actrec.gov.in; nk.manjunath@gmail.comPurpose: To understand the difficulties that happen during the quality of life (QoL) data collection in a pandemic and provide measures to overcome them.Methods: We analyzed the recruitment and follow-up data of patients in one of our ongoing study whose aim was to collect the Adverse drug reactions and QoL (at regular intervals) in prostate cancer patients who were on docetaxel. Before the pandemic, we could enroll 31 patients in the study over four months. We analyzed the difficulties experienced by these patients and consultants in collecting QoL data during the pandemic, especially in situations with limited availability of resources and also where the patients are not technologically advanced.Results: Due to the pandemic, we could not recruit a single new patient into the study. Complete QoL assessments were available in only two patients, and the disease progressed in five patients. QoL assessment was not possible in 19 of 31 enrolled patients. More than 44% of the enrolled patients had difficulty commuting to the hospital despite transport services to hospitals. Due to the risk of acquiring COVID19 infection during traveling to the hospital, follow-ups were affected.Conclusion: There should be increased support for novel technologies that can successfully capture and transfer patients’ QoL data to the treating consultant.Keywords: pandemic, coronavirus, quality of life, COVID 19Shirsat APashilkar SChavan AKalra DGota VJoshi ANookala Krishnamurthy MDove Medical Pressarticlepandemiccoronavirusquality of lifecovid 19Medicine (General)R5-920Therapeutics. PharmacologyRM1-950ENClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 937-941 (2021)
institution DOAJ
collection DOAJ
language EN
topic pandemic
coronavirus
quality of life
covid 19
Medicine (General)
R5-920
Therapeutics. Pharmacology
RM1-950
spellingShingle pandemic
coronavirus
quality of life
covid 19
Medicine (General)
R5-920
Therapeutics. Pharmacology
RM1-950
Shirsat A
Pashilkar S
Chavan A
Kalra D
Gota V
Joshi A
Nookala Krishnamurthy M
Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
description Aditi Shirsat,1 Siddhi Pashilkar,2 Ashish Chavan,1 Devanshi Kalra,2 Vikram Gota,1,3 Amit Joshi,2,3 Manjunath Nookala Krishnamurthy1,3 1Department of Clinical Pharmacology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India; 2Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India; 3Homi Bhabha National Institute, Mumbai, Maharashtra, IndiaCorrespondence: Manjunath Nookala KrishnamurthyDepartment of Clinical Pharmacology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Sector- 22, Kharghar, Navi Mumbai, 410210, Maharashtra, IndiaTel +91 2268735130Email mnookala@actrec.gov.in; nk.manjunath@gmail.comPurpose: To understand the difficulties that happen during the quality of life (QoL) data collection in a pandemic and provide measures to overcome them.Methods: We analyzed the recruitment and follow-up data of patients in one of our ongoing study whose aim was to collect the Adverse drug reactions and QoL (at regular intervals) in prostate cancer patients who were on docetaxel. Before the pandemic, we could enroll 31 patients in the study over four months. We analyzed the difficulties experienced by these patients and consultants in collecting QoL data during the pandemic, especially in situations with limited availability of resources and also where the patients are not technologically advanced.Results: Due to the pandemic, we could not recruit a single new patient into the study. Complete QoL assessments were available in only two patients, and the disease progressed in five patients. QoL assessment was not possible in 19 of 31 enrolled patients. More than 44% of the enrolled patients had difficulty commuting to the hospital despite transport services to hospitals. Due to the risk of acquiring COVID19 infection during traveling to the hospital, follow-ups were affected.Conclusion: There should be increased support for novel technologies that can successfully capture and transfer patients’ QoL data to the treating consultant.Keywords: pandemic, coronavirus, quality of life, COVID 19
format article
author Shirsat A
Pashilkar S
Chavan A
Kalra D
Gota V
Joshi A
Nookala Krishnamurthy M
author_facet Shirsat A
Pashilkar S
Chavan A
Kalra D
Gota V
Joshi A
Nookala Krishnamurthy M
author_sort Shirsat A
title Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
title_short Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
title_full Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
title_fullStr Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
title_full_unstemmed Effect of the Pandemic on Quality-of-Life Data Collection in Prostate Cancer Patients
title_sort effect of the pandemic on quality-of-life data collection in prostate cancer patients
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/6950c31bdf904c32aff377dd522dc393
work_keys_str_mv AT shirsata effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
AT pashilkars effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
AT chavana effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
AT kalrad effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
AT gotav effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
AT joshia effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
AT nookalakrishnamurthym effectofthepandemiconqualityoflifedatacollectioninprostatecancerpatients
_version_ 1718420731919859712